[TIMECOM] YoY Annual (Unaudited) Result on 31-Dec-2020 [#4]

Stock
[TIMECOM] TIME DOTCOM BHD
Announcement Date
26-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
YoY- 4.46%
Quarter Report
Latest QR
Upcoming QR
TIMECOM's Result
TIMECOM's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 1,590,950 1,454,834 1,396,362 1,223,169 1,113,873 983,435 860,696 10.77%
PBT 435,411 517,284 532,724 423,098 328,128 304,811 193,119 14.50%
Tax 2,139,494 -63,674 -135,946 -96,194 -14,092 -16,141 -17,757 -
NP 2,574,905 453,610 396,778 326,904 314,036 288,670 175,362 56.45%
-
NP to SH 2,568,880 449,910 393,160 328,047 314,036 288,670 175,362 56.39%
-
Tax Rate -491.37% 12.31% 25.52% 22.74% 4.29% 5.30% 9.19% -
Total Cost -983,955 1,001,224 999,584 896,265 799,837 694,765 685,334 -
-
Net Worth 4,136,918 3,122,196 3,105,933 3,045,479 2,769,578 2,521,298 2,267,670 10.53%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 1,584,587 569,892 385,894 200,010 169,980 119,995 100,010 58.44%
Div Payout % 61.68% 126.67% 98.15% 60.97% 54.13% 41.57% 57.03% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 4,136,918 3,122,196 3,105,933 3,045,479 2,769,578 2,521,298 2,267,670 10.53%
NOSH 1,846,838 1,836,586 1,825,618 604,261 585,534 583,701 581,453 21.23%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 161.85% 31.18% 28.42% 26.73% 28.19% 29.35% 20.37% -
ROE 62.10% 14.41% 12.66% 10.77% 11.34% 11.45% 7.73% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 86.14 79.21 77.33 202.42 190.23 168.50 148.02 -8.62%
EPS 139.47 24.58 21.63 54.82 53.73 49.56 30.25 28.99%
DPS 85.80 31.03 21.37 33.10 29.03 20.56 17.20 30.69%
NAPS 2.24 1.70 1.72 5.04 4.73 4.32 3.90 -8.82%
Adjusted Per Share Value based on latest NOSH - 604,261
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 86.05 78.69 75.53 66.16 60.25 53.19 46.55 10.77%
EPS 138.95 24.34 21.27 17.74 16.99 15.61 9.49 56.37%
DPS 85.71 30.82 20.87 10.82 9.19 6.49 5.41 58.44%
NAPS 2.2376 1.6888 1.68 1.6473 1.498 1.3637 1.2266 10.53%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 5.40 4.90 4.60 13.26 9.22 8.10 9.10 -
P/RPS 6.27 6.19 5.95 6.55 4.85 4.81 6.15 0.32%
P/EPS 3.88 20.00 21.13 24.42 17.19 16.38 30.17 -28.94%
EY 25.76 5.00 4.73 4.09 5.82 6.11 3.31 40.75%
DY 15.89 6.33 4.65 2.50 3.15 2.54 1.89 42.57%
P/NAPS 2.41 2.88 2.67 2.63 1.95 1.88 2.33 0.56%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/02/24 28/02/23 25/02/22 26/02/21 28/02/20 28/02/19 26/02/18 -
Price 5.50 5.35 4.13 13.90 9.33 7.75 8.04 -
P/RPS 6.38 6.75 5.34 6.87 4.90 4.60 5.43 2.72%
P/EPS 3.95 21.84 18.97 25.60 17.40 15.67 26.66 -27.24%
EY 25.29 4.58 5.27 3.91 5.75 6.38 3.75 37.43%
DY 15.60 5.80 5.17 2.38 3.11 2.65 2.14 39.22%
P/NAPS 2.46 3.15 2.40 2.76 1.97 1.79 2.06 3.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment